Apolipoprotein L1 (APOL1) Genotyping for Chronic Kidney Diseases
Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
SMAD4 Germline Mutation Analysis
Lymphocyte proliferation panel, Blood
Galactosemia
Leukemia/Lymphoma Immunophenotyping by Flow Cytometry, Blood
Hepatitis D Virus (HDV) Antibody, Total
Dihydrocodeine, Urine
Monkeypox Virus DNA by PCR
Measles (Rubeola) Antibody, IgM
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
Methodology
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now